Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

The net prices that health plans paid for medicines — after subtracting rebates, discounts, and fees — fell by 2.8% in last year’s fourth quarter, the largest decline ever measured by SSR Health, a ...

Only rigorous analyses assessing the financial implications of several rounds of negotiation will be able to answer the question that reporters, policymakers, industry stakeholders, and health ...

Medicare has completed its second round of price negotiations for 15 top-selling prescription drugs and posted maximum fair prices, per an Inflation Reduction Act provision. The announced net prices, ...

Drug companies often increase prices at the start of the new year, and 2024 seems to be no exception. There have been about 600 price hikes so far in January, according to the drug price nonprofit ...

Prices for the first 10 drugs negotiated by Medicare fell from their initial net prices, but all drugs except one remained more expensive in the U.S. than in peer countries, researchers said. Compared ...

Please provide your email address to receive an email when new articles are posted on . Humira biosimilar Amjevita can cost $1,558 for commercial plans, a discount of 14% compared with Humira’s 2020 ...